Literature DB >> 1648117

17-alpha-hydroxylase deficiency in three siblings: short- and long-term studies.

C Scaroni1, A Biason, G Carpenè, G Opocher, F Mantero.   

Abstract

We have studied a family (12 members) with 3 patients (2 adult females and 1 pubertal-aged genotypic male) affected by congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency, all of whom presented as phenotypically female subjects with lack of sexual development and with hypokalemic hypertension. The baseline hormonal pattern revealed low glucocorticoid levels (17-hydroxyprogesterone, plasma and urinary cortisol, cortisol secretion rate), as well as androgen (testosterone and dehydroepiandrosterone sulfate) and estrogen (17-beta-estradiol) levels, since the defect is present at both adrenal and gonadal levels. As a consequence ACTH, LH, and FSH concentrations were high. Otherwise steroids not requiring 17-alpha-hydroxylation, such as deoxycorticosterone, corticosterone and their 18-hydroxylated compounds, were secreted in excess with the exception of aldosterone whose levels were undetectable; baseline plasma renin activity levels were suppressed. Short-term dexamethasone treatment normalized potassium and reduced blood pressure and the abnormal mineralocorticoid levels. During chronic ACTH suppression with low doses of glucocorticoids (8 years), electrolyte disturbances were corrected, blood pressure was normalized in 2 cases but only reduced in the third; plasma renin activity returned to normal range within four years in all the patients, while urinary aldosterone was normalized only after 8 years of therapy and became partially responsive to posture, ACTH, angiotensin II, and furosemide. The other mineralocorticoids were reduced but remained above the normal range. The HLA-genotyping in all the family members revealed that the gene responsible for 17-alpha-hydroxylase deficiency was not linked to the HLA system. Measurement of plasma steroids (deoxycorticosterone, corticosterone, aldosterone) in this family revealed that the heterozygotes were different from the control population only in their ACTH-stimulated corticosterone levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648117     DOI: 10.1007/bf03350278

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  [Indications for study of adrenal function by measurement of the cortisol secretion rate].

Authors:  M Boscaro; D Armanini; F Mantero
Journal:  Quad Sclavo Diagn       Date:  1976-03

2.  Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency. Two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries.

Authors:  S R Mallin
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

3.  17-hydroxylation deficiency in man.

Authors:  E G Biglieri; M A Herron; N Brust
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

4.  A new male pseudo-hermaphroditism associated with hypertension due to a block of 17 -hydroxylation.

Authors:  H Bricaire; J P Luton; P Laudat; J C Legrand; G Turpin; P Corvol; M Lemmer
Journal:  J Clin Endocrinol Metab       Date:  1972-07       Impact factor: 5.958

5.  [17-Hydroxylase deficiency. Apropos of a case].

Authors:  M Linquette; A Dupont; A Racadot; J Lefebvre; J P May; J P Cappoen
Journal:  Ann Endocrinol (Paris)       Date:  1971 Jul-Aug       Impact factor: 2.478

6.  Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome.

Authors:  O Goldsmith; D H Solomon; R Horton
Journal:  N Engl J Med       Date:  1967-09-28       Impact factor: 91.245

7.  Combined 17 alpha- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism.

Authors:  W Waldhäusl; K Herkner; P Nowotny; P Bratusch-Marrain
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

8.  Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency.

Authors:  M I New
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

9.  Studies in a phenotypic female with 17-alpha-hydroxylase deficiency.

Authors:  A K Kershnar; D Borut; M D Kogut; E G Biglieri; M Schambelan
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

10.  Two cases of 17 alpha-hydroxylase deficiency--one combined with complete gonadal agenesis.

Authors:  E Tvedegaard; V Frederiksen; K Olgaard; M D Nielsen; J Starup
Journal:  Acta Endocrinol (Copenh)       Date:  1981-10
View more
  3 in total

Review 1.  Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies.

Authors:  Nora Franceschini; Daniel I Chasman; Rhonda M Cooper-DeHoff; Donna K Arnett
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 2.  Recent findings in the genetics of blood pressure and hypertension traits.

Authors:  Nora Franceschini; Alexander P Reiner; Gerardo Heiss
Journal:  Am J Hypertens       Date:  2010-10-14       Impact factor: 2.689

3.  Genetic variation in CYP17A1 is associated with arterial stiffness in diabetic subjects.

Authors:  Soo Jin Yang; Seung-Tae Lee; Won Jun Kim; Se Eun Park; Sung Woo Park; Jong-Won Kim; Cheol-Young Park
Journal:  Exp Diabetes Res       Date:  2012-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.